Effects of decoy molecules targeting NFkappaB transcription factors in Cystic fibrosis IB3-1 cells: Recruitment of NFkappaB to the IL-8 gene promoter and transcription of the IL-8 gene

Artificial DNA: PNA and XNA

Volumn 3, Issue 2, 2012, Pages 1-8

  Finotti, Alessia ^a   Borgatti, Monica ^a   Bezzerri, Valentino ^b   Nicolis, Elena ^b   Lampronti, Ilaria ^a   Dechecchi, Maria Cristina ^b   Mancini, Irene ^a   Cabrini, Giulio ^b   Saviano, Michele ^c,d   Avitabile, Concetta ^c,d   Romanelli, Alessandra ^c,d   Gambari, Roberto ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d CNR   (Italy)

Author keywords

Inflammation; NFkappaB; Peptide nucleic acids; PNA DNA chimeras; Transcription factor decoy

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; OLIGODEOXYRIBONUCLEOTIDE; PEPTIDE NUCLEIC ACID; PEPTIDE NUCLEIC ACID DEOXYRIBONUCLEID ACID PEPTIDE NUCLEIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHIMERA; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; DRUG TARGETING; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IL8 GENE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PSEUDOMONAS AERUGINOSA;

BASE SEQUENCE; CELL LINE; CYSTIC FIBROSIS; DNA; HUMANS; INTERLEUKIN-8; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDE NUCLEIC ACIDS; PROMOTER REGIONS, GENETIC; PSEUDOMONAS AERUGINOSA; TRANSCRIPTION, GENETIC;

PSEUDOMONAS AERUGINOSA;

EID: 84863798183     PISSN: 1949095X     EISSN: 19490968     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004; 23:146-58; PMID:14738247; http://dx.doi.org/10.1183/09031936.03.00057003.
2. Verkman AS, Song Y, Thiagarajah JR. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am J Physiol Cell Physiol 2003; 284:2-15; PMID:12475759.
3. Machen TE. Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 2006; 291:218-30; PMID:16825601; http:// dx.doi.org/10.1152/ajpcell.00605.2005.
4. Puchelle E, De Bentzmann S, Hubeau C, Jacquot J, Gaillard D. Mechanisms involved in cystic fibrosis airway inflammation. Pediatr Pulmonol 2001; 143-5; PMID:11886121.
5. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152:2111-8; PMID:8520783.
6. Jones AM, Martin L, Bright-Thomas RJ, Dodd ME, McDowell A, Moffitt KL, et al. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa. Eur Respir J 2003; 22:503-6; PMID:14516142; http://dx.doi.org/10.1183/09031936.03.00004503.
7. Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW, et al. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 2004; 169:645-53; PMID:14670800; http:// dx.doi.org/10.1164/rccm.200207-765OC.
8. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 2004; 31:377-81; PMID:15381503; http://dx.doi.org/10.1165/ rcmb.2004-0124TR.
9. Groux-Degroote S, Krzewinski-Recchi MA, Cazet A, Vincent A, Lehoux S, Lafitte JJ, et al. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. Biochem J 2008; 410:213-23; PMID:17944600; http://dx.doi.org/10.1042/ BJ20070958.
10. Griesenbach U, Scheid P, Hillery E, de Martin R, Huang L, Geddes DM, et al. Anti-inflammatory gene therapy directed at the airway epithelium. Gene Ther 2000; 7:306-13; PMID:10694811; http://dx.doi. org/10.1038/sj.gt.3301078.
11. Bezzerri V, Borgatti M, Finotti A, Tamanini A, Gambari R, Cabrini G. Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells. J Immunol 2011; 187:6069-81; PMID:22031759; http://dx.doi.org/10.4049/jimmunol.1100821.
12. Bezzerri V, Borgatti M, Nicolis E, Lampronti I, Dechecchi MC, Mancini I, et al. Transcription factor oligodeoxynucleotides to NFkappaB inhibit transcription of IL-8 in bronchial cells. Am J Respir Cell Mol Biol 2008; 39:86-96; PMID:18258920; http://dx.doi. org/10.1165/rcmb.2007-0176OC.
13. Cooper JA Jr, Parks JM, Carcelen R, Kahlon SS, Sheffield M, Culbreth R. Attenuation of interleukin-8 production by inhibiting nuclear factorkappaB translocation using decoy oligonucleotides. Biochem Pharmacol 2000; 59:605-13; PMID:10677576; http:// dx.doi.org/10.1016/S0006-2952(99)00375-5.
14. Mann MJ. Transcription factor decoys: a new model for disease intervention. Ann NY Acad Sci 2005; 1058:128-39; PMID:16394132; http://dx.doi. org/10.1196/annals.1359.021.
15. Mann MJ, Dzau VJ. Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 2000; 106:1071-5; PMID:11067859; http://dx.doi. org/10.1172/JCI11459.
16. Gambari R. Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy. Curr Med Chem 2004; 11:1253-63; PMID:15134518.
17. Dzau VJ. Transcription factor decoy. Circ Res 2002; 90:1234-6; PMID:12089058; http://dx.doi. org/10.1161/01.RES.0000025209.24283.73.
18. Borgatti M, Romanelli A, Saviano M, Pedone C, Lampronti I, Breda L, et al. Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum. Oncol Res 2003; 13:279-87; PMID:12688679.
19. Nielsen PE, Egholm M, Berg RH, Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 1991; 254:1497-500; PMID:1962210; http:// dx.doi.org/10.1126/science.1962210.
20. Borgatti M, Finotti A, Romanelli A, Saviano M, Bianchi N, Lampronti I, et al. Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression. Curr Drug Targets 2004; 5:735-44; PMID:15578953; http://dx.doi. org/10.2174/1389450043345155.
21. Egholm M, Buchardt O, Christensen L, Behrens C, Freier SM, Driver DA, et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 1993; 365:566-8; PMID:7692304; http://dx.doi. org/10.1038/365566a0.
22. Demidov VV, Potaman VN, Frank-Kamenetskii MD, Egholm M, Buchard O, Sönnichsen SH, et al. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem Pharmacol 1994; 48:1310-3; PMID:7945427; http://dx.doi.org/10.1016/0006-2952(94)90171-6.
23. Borgatti M, Boyd DD, Lampronti I, Bianchi N, Fabbri E, Saviano M, et al. Decoy molecules based on PNADNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol Res 2005; 15:373-83; PMID:16491955.
24. Penolazzi L, Borgatti M, Lambertini E, Mischiati C, Finotti A, Romanelli A, et al. Peptide nucleic acid-DNA decoy chimeras targeting NFkappaB transcription factors: Induction of apoptosis in human primary osteoclasts. Int J Mol Med 2004; 14:145-52; PMID:15254756.
25. Gambari R. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers. Curr Pharm Des 2001; 7:1839-62; PMID:11562312; http://dx.doi. org/10.2174/1381612013397087.
26. Uhlmann E. Peptide nucleic acids (PNA) and PNADNA chimeras: from high binding affinity towards biological function. Biol Chem 1998; 379:1045-52; PMID:9792437.
27. Borgatti M, Lampronti I, Romanelli A, Pedone C, Saviano M, Bianchi N, et al. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 2003; 278:7500-9; PMID:12446679; http://dx.doi. org/10.1074/jbc.M206780200.
28. Borgatti M, Breda L, Cortesi R, Nastruzzi C, Romanelli A, Saviano M, et al. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NFkappaB transcription factors. Biochem Pharmacol 2002; 64:609-16; PMID:12167479; http://dx.doi.org/10.1016/S0006-2952(02)01188-7.
29. Romanelli A, Pedone C, Saviano M, Bianchi N, Borgatti M, Mischiati C, et al. Molecular interactions with nuclear factor kappaB (NFkappaB) transcription factors of a PNA-DNA chimera mimicking NFkappaB binding sites. Eur J Biochem 2001; 268:6066-75; PMID:11733000; http://dx.doi.org/10.1046/j.0014-2956.2001.02549.x.
30. Shi F, Gounko NV, Wang X, Ronken E, Hoekstra D. In situ entry of oligonucleotides into brain cells can occur through a nucleic acid channel. Oligonucleotides 2007; 17:122-33; PMID:17461769; http://dx.doi. org/10.1089/oli.2007.0034.
31. Weyermann J, Lochmann D, Zimmer A. Comparison of antisense oligonucleotide drug delivery systems. J Control Release 2004; 100:411-23; PMID:15567506; http://dx.doi.org/10.1016/j.jconrel.2004.08.027.
32. Shi F, Hoekstra D. Effective intracellular delivery of oligonucleotides in order to make sense of antisense. J Control Release 2004; 97:189-209; PMID:15196747; http://dx.doi.org/10.1016/j.jconrel.2004.03.016.
33. Borgatti M, Bezzerri V, Mancini I, Nicolis E, Dechecchi MC, Lampronti I, et al. Induction of IL-6 gene expression in a CF bronchial epithelial cell line by Pseudomonas aeruginosa is dependent on transcription factors belonging to the Sp1 superfamily. Biochem Biophys Res Commun 2007; 357:977-83; PMID:17466942; http://dx.doi.org/10.1016/j. bbrc.2007.04.081.
34. Moggio L, Romanelli A, Gambari R, Bianchi N, Borgatti M, Fabbri E, et al. Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity. Biopolymers 2007; 88:815-22; PMID:17918186; http://dx.doi.org/10.1002/ bip.20857.
35. Saviano M, Romanelli A, Bucci E, Pedone C, Mischiati C, Bianchi N, et al. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NFkappaB binding sites. J Biomol Struct Dyn 2000; 18:353-62; PMID:11149512; http://dx.doi.org /10.1080/07391102.2000.10506672.
36. Will DW, Breipohl G, Langner D, Knolle J, Uhlmann E. The synthesis of polyamide nucleic acids using a novel monomethoxytrityl protecting-group strategy. Tetrahedron 1995; 51:12069-82; http://dx.doi. org/10.1016/0040-4020(95)00766-2.
37. Dechecchi MC, Nicolis E, Bezzerri V, Vella A, Colombatti M, Assael BM, et al. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am J Respir Cell Mol Biol 2007; 36:615-24; PMID:17197571; http:// dx.doi.org/10.1165/rcmb.2006-0200OC.
38. Finotti A, Treves S, Zorzato F, Gambari R, Feriotto G. Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locus. BMC Mol Biol 2008; 16:9:110.